Small Animal Core

$368,218P01FY2011AINIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

Paper 39649241 Paper 39291632 Paper 39042769 Paper 38452918 Paper 37820009 Paper 37251390 Paper 36752272 Paper 36621453 Paper 36507998 Paper 36454036 Paper 36227981 Paper 36198911 Paper 35663933 Paper 35644520 Paper 35315788 Paper 34695489 Paper 34418164 Paper 34054721 Paper 33904221 Paper 33611150 Paper 33017208 Paper 32909301 Paper 32875283 Paper 32796179 Paper 32002911 Paper 32002908 Paper 31583677 Paper 31565822 Paper 31556182 Paper 31544995 Paper 31495971 Paper 31385886 Paper 31293016 Paper 30920391 Paper 30814997 Paper 30379724 Paper 30136356 Paper 29913045 Paper 29913040 Paper 29722117 Paper 29708512 Paper 29624743 Paper 29527745 Paper 29513380 Paper 29296847 Paper 28989853 Paper 28966117 Paper 28945472 Paper 28937406 Paper 28874533 Paper 28826941 Paper 28737658 Paper 28725880 Paper 28639977 Paper 28602591 Paper 28591112 Paper 28489305 Paper 28251801 Paper 28117931 Paper 27623510 Paper 27607583 Paper 27606556 Paper 27394641 Paper 27236363 Paper 27232934 Paper 27230788 Paper 27145342 Paper 27005321 Paper 26824989 Paper 26718119 Paper 26589781 Paper 26541524 Paper 26499257 Paper 26085679 Paper 26039215 Paper 25894409 Paper 25676635 Paper 25612490 Paper 25303316 Paper 25287706 Paper 25278264 Paper 25243512 Paper 25243511 Paper 25208846 Paper 25205248 Paper 25172498 Paper 25165006 Paper 24933456 Paper 24798308 Paper 24592880 Paper 24591363 Paper 24517437 Paper 24517424 Paper 24517422 Paper 24505337 Paper 24462799 Paper 24459229 Paper 24388175 Paper 24304495 Paper 24289469

Abstract

The role of Core C is to provide mouse models to all research projects. We will pursue two specific aims. Aim 1 includes: 1) coordinating, purchasing and housing immunodeficient (NOD/SCID and NOD/SCID/yc KO) mice, which will be used to prepare humanized mice (see Aim 2) for all projects (except Project 3, as explained in the Research Strategies section);and 2) maintaining and producing immunodeficient porcine cytokine transgenic mice. The porcine cytokine transgenic mice generated in this laboratory provide an excellent murine model for porcine hematopoietic stem/progenitor cell transplantation. These mice will be used to evaluate CD47 gene transduction in porcine hematopoietic progenitors (Project 2), and to prepare hu-mice for assessing human NK cell tolerance to porcine xenografts by mixed hematopoietic chimerism (Project 3). Aim 2 is to provide humanized mouse (hu-mouse) models, including: 1) 'standard'hu-mice with a functional human immune system;2) hu-mice with porcine thymic grafts;3) transgenic hu-mice that express human CD39 transgenes, and 4) porcine chimeric hu-mice with porcine hematopoietic cells expressing a HLA-E/human B2m/peptide trimer. Our approach to generating hu-mice with a functional immune system is to transplant fetal thymus tissue (under renal capsule) and CD34+ hematopoietic stem/progenitor cells (i.v.) in immunodeficient mice. The 'standard'hu-mice will be used to test the immunoregulatory reagents/protocols to be used in non-human primates (Projects 1 and 2). The HLAE/ human p2m/peptide trimer-expressing porcine chimeric hu-mice will be used to assess the potential of NK cell inhibitory ligand expression on porcine cells to induce human NK cell tolerance in Project 3. Hu-mice with porcine thymic grafts and human CD39-overexpresing hu-mice will be used in Project 4 to investigate the role of CD39 in human regulatory T cell development in xenogeneic porcine thymic grafts. The core will prepare and validate the mouse models, and then either perform the proposed experiments (for Projects 1 and 2) or provide 'ready-to-use'models to the investigators (for Projects 3 and 4). As detailed in each research components, these mouse models are essential to the success of this program project.

View original record on NIH RePORTER →